Gaingels

Gaingels is a venture investment syndicate founded in 2014 and based in Burlington, Vermont, dedicated to supporting the LGBT+ community and its allies. The organization invests in companies led by LGBT+ founders and executives at all stages of development, as well as in established firms committed to enhancing their diversity and inclusivity. With a global portfolio comprising over 130 companies and $70 million in investment capital deployed, Gaingels plays a vital role in fostering an inclusive business environment. Additionally, the Gaingels network actively assists its portfolio companies in identifying and recruiting diverse talent for their leadership teams, while cultivating a vibrant community of industry leaders, investors, and entrepreneurs committed to driving positive social change through business initiatives.

Marc Baum

Investor

Jesse Curran

Principal

Ashley Flucas

Venture Partner

Rachael Foo

Investor

Todd Havill

Research Operations and Principal, Investment

Surya Jayaweera

Angel Investor

Jennifer Jeronimo

CEO and General Partner

Chris Leiter

Venture Partner and Investor

Jake Prigoff MD

General Partner

Alexandra Tanner

Investor

Past deals in Image Recognition

VerImmune

Seed Round in 2022
VerImmune, based in Baltimore, Maryland, is an immuno-oncology company focused on developing innovative cancer therapies through its proprietary technology, Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This unique approach aims to harness pre-existing immune memory from pathogens or childhood vaccines to target and redirect the immune system toward tumors. By doing so, VerImmune seeks to address significant challenges in cancer treatment, particularly for patients with limited options or those who have developed resistance to conventional therapies. The company's strategy promises to offer low toxicity and sustained benefits across a diverse range of cancer types, potentially transforming the treatment landscape for those with difficult-to-treat malignancies.

Magnetic Insight

Series B in 2022
Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

Base64

Seed Round in 2022
Base64.ai automates all document processes using Generative AI and Large Language Models. The startup is disrupting the $100 billion Intelligent Document Processing market with its unique capability to understand any document without training. It has four patent applications, supports over 2,800 document types, and has 400+ no-code integrations. It's at $1.2m GAAP ARR with 1.5x growth in the last three months. The startup was funded $2m in Q2 2022 by Long Journey Ventures, Prime Zero, and Sequoia Scout. The founder, Ozan Bilgen, was a software engineer/manager at Microsoft, Netflix, PayPal, Uber, and Palantir.

Kneron

Series B in 2021
Kneron, Inc. is a company that designs and develops integrated software and hardware solutions for artificial intelligence applications, focusing on enabling AI functionality at the edge. Founded in 2015 and headquartered in San Diego, California, Kneron has additional offices in Taipei City, Zhuhai City, and Shenzhen City, China. The company's offerings include neural processing units (NPUs) tailored for smart homes, smart surveillance, smartphones, and wearable devices. Kneron also provides visual recognition software capable of on-device recognition of human faces, bodies, gestures, objects, and scenes. Their products support a range of applications, from robots and drones to Internet of Things (IoT) devices, ensuring real-time recognition and analysis without relying on cloud connections.

Scopio

Venture Round in 2021
Scopio, LLC is an image search engine and licensing platform that connects photographers and visual artists with businesses, brands, and organizations seeking visual content. Founded in 2015 and based in New York, Scopio specializes in user-generated images and videos sourced from social media. The platform allows users to license photographs with customizable messages and build libraries of content, while also streamlining the copyright process for these images. By leveraging artificial intelligence, Scopio enhances accessibility for diverse artists from around the world, enabling them to showcase their work and connect with potential clients. Scopio aims to create the largest repository of visual talent, allowing users to easily search, license, and utilize creative content.

EIO Diagnostics

Seed Round in 2021
EIO Diagnostics Inc. is a Canadian company specializing in mastitis detection systems for dairy cattle. Founded in 2017 and based in Duncan, the company has developed the FirstLook Mastitis system, which employs a multispectral sensor to capture images of the udder as cows enter the milk parlor. This technology utilizes infrared image analysis and computer vision to automate the detection of early indicators of mastitis, allowing farmers to prevent infections before they occur. By installing a single sensor at the entry of the rotary milking system, EIO Diagnostics enables farmers to monitor udder health efficiently, thereby enhancing livestock health and improving milk quality while reducing labor and associated costs.

Nines

Series A in 2019
Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.